GIRSHICK BIRGIT (Corporate Executive VP & COO) sold 15.3% of their position (6.50K shares) of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. on the open market
Open‑market sale worth $1.82M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001100682-26-000132
Officer· Corporate Executive VP & COO
Since Mar 2026
-6.50K
Net shares
Net seller
$1.82M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
$179.66
Trade value
$1.17M
% of position
18.0%
8/11/2026
36.01K→42.51K
Common Stock
Direct
Shares
−6.50K
Price / share
$279.90
Trade value
$1.82M
% of position
15.3%
8/11/2026
42.51K→36.01K
Total
Net shares
+0.00
Net value
-$651.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2026 | M · Option Exercise | +6.50K | $179.66 | $1.17M | 18.0% | 36.01K | 42.51K |
| Common Stock Direct | 8/11/2026 | S · Sale | −6.50K | $279.90 | $1.82M | 15.3% | 42.51K | 36.01K |
| Total | +0.00 | -$651.56K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
179.66
Held after
0.00
Exercisable
—
8/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock6.50K shares | 8/11/2026 | M · Option Exercise | −6.50K | 179.66 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned43.80K
Total
43.80K indirect43.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 43.80K | Indirect |
| Total | 43.80K | 43.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported